PHARMALAC HOLDING DANMARK A/S: Financial statements 2015
CVR: 36022426
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
PHARMALAC HOLDING DANMARK A/S (CVR 36022426) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -13,930 and a net result of DKK 76,173. Equity in the 2015 report amounted to DKK 917,263. The solvency ratio was 90.3%.
- Gross Profit
- DKK -13,930
- Profit/Loss
- DKK 76,173
- Equity
- DKK 917,263
- Total Assets
- DKK 1,015,284
Official annual report
How creditworthy is PHARMALAC HOLDING DANMARK A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
PHARMALAC HOLDING DANMARK A/S has published its interim report for the period June 26, 2014 to December 31, 2014.
As of June 12, 2015, Søren Sten Rasmussen has joined the board of directors of PHARMALAC HOLDING DANMARK A/S.
As of June 12, 2015, Henrik Simonsen has joined the board of directors of PHARMALAC HOLDING DANMARK A/S.
As of June 12, 2015, Martin Lavesen has left the board of directors of PHARMALAC HOLDING DANMARK A/S.
As of June 12, 2015, Jess Thiersen has left the board of directors of PHARMALAC HOLDING DANMARK A/S.
As of June 12, 2015, Henrik Simonsen is registered as director of PHARMALAC HOLDING DANMARK A/S.
As of June 12, 2015, Martin Lavesen has stepped down as direktion of PHARMALAC HOLDING DANMARK A/S.
About PHARMALAC HOLDING DANMARK A/S
PHARMALAC HOLDING DANMARK A/S was a Danish company of the type Aktieselskab based in København V, founded in 2014. The company has been dissolved on 29 December 2017. The company was registered under the industry Uoplyst. In 2016, the company reported a gross profit of DKK -250 and a net result of DKK -159,859 compared with DKK 76,173 the year before. Equity in the 2016 report amounted to DKK 757,404.